Brief: Chinese Patent Granted For A*Star Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
01/08/2023 12:16
Aug 1 (Reuters) - CytoMed Therapeutics Ltd GDTC.O :
* CHINESE PATENT GRANTED FOR A*STAR SPINOFF, CYTOMED
THERAPEUTICS'
LICENSED ALLOGENEIC CAR-GAMMA DELTA T CELL TECHNOLOGY
Source text for Eikon: ID:nPnrPV6za
Further company coverage: GDTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million